GO:2001286 regulation of caveolin-mediated endocytosis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001286 (regulation of caveolin-mediated endocytosis) is a biological process that modulates the frequency, rate or extent of caveolin-mediated endocytosis, a clathrin-independent uptake route driven by caveolae.
• Caveolin-1 (CAV1) is the structural and signaling core of caveolae; its endocytic trafficking is controlled by Rab21, which directs caveolin-1-positive vesicles during neurite pruning.
• Regulation of caveolin-mediated endocytosis controls the surface availability of signaling receptors and channels, including TRPV5, whose internalization is impaired by uromodulin, and dopamine receptors in the brain.
• The pathway is exploited for delivery of large cargoes, including ultrasound-assisted transport of macromolecules into the brain via caveolin-mediated transcytosis and nanoparticle or mRNA delivery platforms.
• Dysregulation of caveolin-mediated endocytosis is linked to kidney calcium handling, neurodevelopmental processes, and inflammatory responses in intestinal cells.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with imaging and proteomics, are the main tools for dissecting how individual genes regulate this process.
Description
Regulation of caveolin-mediated endocytosis (GO:2001286) is the biological process that controls the frequency, rate or extent of caveolin-mediated endocytosis, a clathrin-independent internalization route that depends on caveolae, small flask-shaped membrane invaginations enriched in caveolin proteins. Because caveolae are abundant in endothelial cells, adipocytes, fibroblasts and epithelial cells, the regulation of this uptake route directly influences how cells sample their environment and how they adjust surface receptor levels. The term is therefore central to studies of membrane trafficking, signal transduction and drug delivery. Caveolin-mediated endocytosis is not a single fixed event but a tunable process. Its rate can be increased or decreased by extracellular ligands, intracellular signaling cascades and trafficking regulators such as Rab21, which controls caveolin-1-positive endocytic trafficking during immature neurite pruning. Regulation of this pathway also determines the fate of cargoes ranging from uromodulin-regulated ion channels to dopamine receptors in the brain and large therapeutic macromolecules delivered across the blood-brain barrier. For researchers, GO:2001286 provides a precise annotation for experiments that perturb the rate of caveolin-dependent uptake, whether by genetic manipulation, pharmacological inhibition or cargo engineering.
regulation of caveolin-mediated endocytosis At A Glance
| GO ID | GO:2001286 |
|---|---|
| GO term | regulation of caveolin-mediated endocytosis |
| Ontology | biological_process |
| Synonym | regulation of caveolae-dependent endocytosis; regulation of caveolae-mediated endocytosis; regulation of caveolin-dependent endocytosis |
| Definition | Any process that modulates the frequency, rate or extent of caveolin-mediated endocytosis. |
| Major function | Tuning the rate of caveolin- and caveolae-dependent internalization of cargoes and surface receptors |
| Key structural protein | Caveolin-1 (CAV1), the scaffold of caveolae and a substrate of regulated trafficking |
| Representative regulators | Rab21 and other Rab GTPases that control caveolin-1 endocytic trafficking |
| Physiological examples | Uromodulin-dependent impairment of TRPV5 endocytosis; dopamine receptor endocytosis in brain |
| Therapeutic relevance | Ultrasound-assisted caveolin-mediated transcytosis for brain delivery of large cargoes; nanoparticle and mRNA delivery |
What Is GO:2001286?
In the QuickGO ontology, GO:2001286 (regulation of caveolin-mediated endocytosis) is defined as any process that modulates the frequency, rate or extent of caveolin-mediated endocytosis. It is a biological_process term with synonyms including regulation of caveolae-dependent endocytosis, regulation of caveolae-mediated endocytosis and regulation of caveolin-dependent endocytosis. In practice, this means the term covers all molecular events that set the speed or amount of caveolin-dependent internalization, rather than the internalization machinery itself.
Why Is regulation of caveolin-mediated endocytosis Important in Cell Biology?
Regulation of caveolin-mediated endocytosis matters because it is a decision point for how cells internalize receptors, channels and extracellular cargo, and because it can be manipulated for therapy. When the rate of caveolin-dependent uptake changes, the surface abundance of signaling proteins such as TRPV5 and dopamine receptors changes with it, altering calcium handling and neuronal signaling. The same pathway is used by delivery systems that carry large macromolecules into the brain after ultrasound exposure, and by nanoparticle or mRNA formulations that must be tuned for efficient cellular entry. Consequently, genes that regulate this process are candidate targets for kidney, neurological and inflammatory conditions, and are also key variables in the design of biologics and gene medicines.
• Controls surface levels of ion channels and receptors, including TRPV5 in kidney and dopamine receptors in brain.
• Determines the efficiency of caveolin-mediated transcytosis for brain delivery of large cargoes.
• Influences nanoparticle and mRNA delivery, where uptake route choice affects therapeutic performance.
• Regulates caveolin-1 trafficking during neuronal morphogenesis, including immature neurite pruning.
• Modulates inflammatory responses in intestinal epithelial cells exposed to exosome-like nanoparticles.
• Provides a mechanistic explanation for clathrin-independent entry of pathogens and cargoes distinct from clathrin-mediated routes.
• Offers a druggable node for altering membrane trafficking without globally blocking endocytosis.
• Serves as an annotation target for CRISPR screens that score endocytic phenotypes.
What Happens During regulation of caveolin-mediated endocytosis?
Initiation at caveolae and cargo selection
In simple terms: The cell first decides which cargo will enter through caveolae and when.
Regulation begins with the availability of caveolae at the plasma membrane and the selection of cargo. Caveolin-1 forms the structural core of these invaginations, and its trafficking is actively controlled rather than spontaneous. Cargo such as uromodulin-sensitive channels or large macromolecules must be presented at caveolae for uptake to occur, and the rate of this step sets the overall flux through the pathway.
Signaling control of uptake rate
In simple terms: Signals inside the cell speed up or slow down caveolae formation and internalization.
Intracellular signaling cascades modulate the frequency of caveolin-mediated endocytosis. For example, uromodulin impairs caveolin-mediated endocytosis of TRPV5, thereby increasing channel abundance at the membrane. In brain, endocytosis of dopamine receptors is regulated as part of receptor signaling, showing that neurotransmitter systems can tune caveolin-dependent uptake. These examples illustrate that regulation is context-dependent and ligand-sensitive.
Vesicle trafficking and Rab GTPase control
In simple terms: Once formed, caveolin vesicles are routed by molecular switches called Rab proteins.
Rab21 regulates caveolin-1-mediated endocytic trafficking and is required for immature neurite pruning, demonstrating that Rab GTPases act as regulators of the pathway rather than passive carriers. This step determines whether internalized caveolin-1 is recycled, degraded or directed to specific membrane domains, and thus feeds back on the rate of subsequent uptake events.
Cargo fate and downstream consequences
In simple terms: What happens after uptake decides the biological outcome.
After internalization, cargo can be sorted to endosomes, recycled or degraded, and this fate is part of the regulatory logic of the pathway. In delivery applications, caveolin-mediated transcytosis allows large cargoes to cross endothelial barriers into the brain after ultrasound, so regulation of the pathway directly affects therapeutic distribution. Similarly, nanoparticle and mRNA delivery platforms depend on which endocytic route is engaged, making regulation of caveolin-mediated endocytosis a design parameter.
Cross-talk with other endocytic routes
In simple terms: Caveolin uptake does not work alone; it is balanced against other entry routes.
Cells can internalize material by macropinocytosis, clathrin-mediated endocytosis and caveolin-mediated endocytosis, and the relative contribution of each route is regulated. Bovine respiratory syncytial virus enters cells through clathrin-mediated endocytosis controlled by PI3K-Akt and Src-JNK pathways, illustrating how signaling pathways can select between endocytic mechanisms. Regulation of caveolin-mediated endocytosis therefore includes the balance between competing uptake routes.
Key Genes Involved in GO:2001286 regulation of caveolin-mediated endocytosis
The following genes and proteins have documented roles in caveolin-mediated endocytosis or its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAV1 | Structural core of caveolae; subject of regulated endocytic trafficking | Central marker for caveolin-mediated uptake and transcytosis studies |
| RAB21 | Regulates caveolin-1-mediated endocytic trafficking during neurite pruning | Model for Rab-dependent control of caveolin vesicle routing |
| TRPV5 | Calcium channel whose endocytosis is impaired by uromodulin | Readout for regulation of caveolin-mediated endocytosis in kidney cells |
| UMOD | Uromodulin; upregulates TRPV5 by impairing caveolin-mediated endocytosis | Tool to manipulate pathway rate in epithelial models |
| DRD1/DRD2 | Dopamine receptors whose endocytosis is part of brain signaling | Neuronal model for receptor-specific regulation of uptake |
| PIK3CA/PI3K | PI3K-Akt signaling influences endocytic route selection | Pathway node for comparing clathrin- and caveolin-dependent entry |
| SRC | Src-JNK signaling regulates clathrin-mediated entry and route choice | Comparator for signaling control of endocytosis |
| MAPK8/JNK | JNK pathway participates in endocytic regulation | Candidate modifier of uptake route balance |
| RAB5 | Early endosomal GTPase downstream of internalization | Marker for tracking cargo after caveolin uptake |
| RAB7 | Late endosomal routing | Marker for degradation versus recycling decisions |
| CAV2 | Caveolin family member co-assembling with caveolin-1 | Candidate modifier of caveolae stability |
| CAVIN1 | Caveolae-associated protein supporting caveolar structure | Target for perturbing caveolae abundance |
| EPS15 | Endocytic adaptor in clathrin-dependent uptake | Control for route-specific experiments |
| CLTC | Clathrin heavy chain; defines clathrin-mediated route | Comparator for caveolin-independent uptake |
| ACTB | Actin cytoskeleton supporting membrane remodeling | Cytoskeletal control of uptake |
| RAC1 | Rho-family GTPase implicated in membrane dynamics | Modifier of macropinocytosis versus caveolin uptake |
| CD44 | Surface receptor used in nanoparticle uptake studies | Cargo-receptor model for endocytic route analysis |
| ALB | Model macromolecular cargo for transcytosis | Cargo tracer for caveolin-mediated transcytosis |
How Is regulation of caveolin-mediated endocytosis Regulated?
Regulation of caveolin-mediated endocytosis is itself regulated at multiple levels. Rab21 controls caveolin-1-mediated endocytic trafficking, linking vesicle routing to developmental processes such as neurite pruning. Signaling pathways, including PI3K-Akt and Src-JNK, influence which endocytic route is used, providing a mechanism for growth factors and stress kinases to shift uptake away from or toward caveolin-dependent entry. Ligand availability also matters: uromodulin impairs caveolin-mediated endocytosis of TRPV5, thereby altering channel surface expression, and dopamine receptor endocytosis is integrated into neurotransmitter signaling in the brain. Finally, the physical form of the cargo, such as nanoparticles or mRNA formulations, can bias the pathway and thus acts as an extrinsic regulator of uptake rate.
regulation of caveolin-mediated endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UMOD/TRPV5 | Renal calcium handling and tubular transport | Kidney epithelial cell line with UMOD overexpression and TRPV5 endocytosis readout |
| RAB21/CAV1 | Neurodevelopmental neurite pruning | Primary neurons or neuronal cell line with RAB21 knockout and caveolin-1 trafficking imaging |
| DRD1/DRD2 | Dopaminergic signaling in brain | Neuronal cultures treated with dopamine receptor ligands and endocytosis assays |
| CAV1 | Caveolin-mediated transcytosis for brain delivery | Endothelial barrier model with ultrasound-assisted cargo transport |
| CD44/nanoparticle cargo | Inflammatory response in intestinal epithelium | Caco-2 cells treated with exosome-like nanoparticles and inflammatory markers |
Kidney calcium handling and uromodulin-related disorders
Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis, directly connecting regulation of this pathway to renal calcium transport. Perturbations in this regulatory axis are therefore relevant to disorders of calcium homeostasis and to models of tubular function.
Neurological and neurodevelopmental processes
Rab21 regulates caveolin-1-mediated endocytic trafficking to promote immature neurite pruning, a developmental process required for proper neuronal circuit formation. Endocytosis of dopamine receptors in the brain further links regulated caveolin-dependent uptake to dopaminergic signaling.
Inflammation and intestinal epithelial biology
Ginger exosome-like nanoparticles show anti-inflammatory effects in intestinal Caco-2 cells, a setting where nanoparticle uptake and endocytic routing influence the cellular response. This positions regulation of caveolin-mediated endocytosis as a variable in inflammatory signaling studies.
Drug and nucleic acid delivery
Caveolin-mediated transcytosis facilitates transport of large cargoes into the brain via ultrasound, and iterative delivery strategies enhance mRNA therapy. Regulation of this pathway therefore affects the efficacy of biologics and gene medicines that depend on caveolin-dependent entry.
From regulation of caveolin-mediated endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate regulator change the rate of caveolin-mediated endocytosis? | CRISPR knockout cell line with caveolin-1 uptake assay |
| Does a specific phosphorylation site control caveolin-1 trafficking? | Point-mutation knock-in of the phospho-site in CAV1 |
| Can a reporter track caveolin vesicles in live cells? | Tagged knock-in of CAV1 with fluorescent protein |
| Does overexpression of a regulator increase caveolin-dependent cargo uptake? | Stable overexpression cell line with quantitative uptake readout |
| Which genes modify caveolin-mediated transcytosis? | Pooled CRISPR library screening in endothelial barrier models |
| How does a disease variant alter receptor endocytosis? | Patient-derived cells with isogenic knock-in of the variant |
How to Study the regulation of caveolin-mediated endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence imaging | Rate and route of caveolin-1 vesicle formation | Tracking regulated uptake in knockout versus control cells |
| Cargo uptake assay | Amount of internalized ligand or nanoparticle | Comparing caveolin-dependent versus macropinocytic entry |
| CRISPR knockout | Loss-of-function effect on pathway rate | Testing candidate regulators of caveolin-mediated endocytosis |
| CRISPR knock-in tagging | Localization and dynamics of endogenous caveolin-1 | Visualizing regulated trafficking in native context |
| Proximity proteomics | Protein interactors of caveolin-1 complexes | Identifying new regulators and Rab effectors |
| Transcriptomics (RNA-seq) | Gene expression changes after pathway perturbation | Linking endocytic regulation to inflammatory or signaling programs |
| Barrier transcytosis assay | Transport of large cargo across endothelial monolayers | Evaluating brain delivery strategies |
| mRNA delivery assay | Functional protein output after formulated mRNA uptake | Optimizing delivery platforms that use caveolin-dependent entry |
Imaging-based endocytosis assays
Fluorescence imaging of caveolin-1 and cargo tracers is the primary method to measure the rate of caveolin-mediated endocytosis and its regulation. Live-cell imaging of tagged caveolin-1 allows tracking of vesicle formation, trafficking and recycling in response to genetic perturbation.
CRISPR perturbation combined with uptake readouts
Knockout or knock-in of candidate regulators followed by quantitative cargo uptake provides causal evidence for a gene's role in regulating the pathway. Pooled screens can nominate modifiers of caveolin-mediated transcytosis when coupled to a selectable or sortable cargo.
Proteomics and interactome analysis
Affinity purification or proximity labeling of caveolin-1 complexes identifies proteins that may regulate the pathway, including Rab GTPases and cytoskeletal factors. Comparing proteomes of knockout and control cells reveals downstream consequences of altered endocytic rate.
Delivery and transcytosis models
Endothelial barrier models and in vivo ultrasound-assisted delivery systems test whether regulation of caveolin-mediated endocytosis changes transport of large cargoes such as albumin or mRNA formulations. Nanoparticle uptake studies complement these assays by distinguishing caveolin-dependent from macropinocytic entry.
How CRISPR Can Be Used to Study GO:2001286 regulation of caveolin-mediated endocytosis
Knockout
CRISPR knockout of candidate genes such as RAB21 or CAV1 provides loss-of-function evidence for their role in regulating caveolin-mediated endocytosis. Knockout cells can be challenged with fluorescent cargo to quantify changes in uptake rate and to determine whether the pathway is required for specific biological outcomes.
Point Mutation
Point mutation models introduce specific amino acid changes, for example in caveolin-1 or a regulator, to test whether a particular residue or modification controls endocytic rate. These models separate the regulatory function of a protein from its structural role.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous loci enables tracking of caveolin-1 trafficking under physiological expression levels. Knock-in of disease-associated variants allows testing of how a specific allele alters regulation of caveolin-mediated endocytosis.
Overexpression
Overexpression of a candidate regulator or of caveolin-1 itself tests sufficiency: whether increased protein levels raise the rate of caveolin-mediated uptake or transcytosis. Overexpression models are also used to produce sufficient material for biochemical and proteomic analysis of the pathway.
How EDITGENE Supports regulation of caveolin-mediated endocytosis Research
Researchers studying regulation of caveolin-mediated endocytosis-related genes often need to determine whether a candidate gene is causally involved in setting the rate of caveolin-dependent uptake, or whether it is merely correlated with a phenotype. Answering that question requires precise genetic models in which a single gene can be removed, modified or tagged without confounding off-target effects, combined with quantitative endocytosis readouts.
Contact EDITGENE today to design your custom CRISPR model for regulation of caveolin-mediated endocytosis research.
Frequently Asked Questions About regulation of caveolin-mediated endocytosis
What is regulation of caveolin-mediated endocytosis (GO:2001286)?
It is the biological process that modulates the frequency, rate or extent of caveolin-mediated endocytosis, a caveolae-dependent uptake route.
What genes are involved in regulation of caveolin-mediated endocytosis?
Documented players include CAV1, RAB21, TRPV5, UMOD and dopamine receptors, with signaling pathways such as PI3K-Akt and Src-JNK influencing route selection.
How is caveolin-mediated endocytosis different from clathrin-mediated endocytosis?
Caveolin-mediated endocytosis depends on caveolae and caveolin-1, whereas clathrin-mediated endocytosis uses clathrin-coated pits; the two routes can be regulated independently and compete for cargo.
Why is regulation of caveolin-mediated endocytosis important for drug delivery?
Caveolin-mediated transcytosis enables transport of large cargoes into the brain after ultrasound, and the pathway is engaged by nanoparticle and mRNA delivery systems.
Which diseases are linked to caveolin-mediated endocytosis?
Links have been described in renal calcium handling through uromodulin and TRPV5, in neurodevelopmental neurite pruning via Rab21, and in intestinal inflammation models.
What is the role of Rab21 in caveolin-mediated endocytosis?
Rab21 regulates caveolin-1-mediated endocytic trafficking and is required for immature neurite pruning.
How does uromodulin affect caveolin-mediated endocytosis?
Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis of the channel.
How can I study regulation of caveolin-mediated endocytosis in the lab?
Common approaches include live-cell imaging of tagged caveolin-1, cargo uptake assays, CRISPR knockout or knock-in of candidate genes, and proteomic analysis of caveolin-1 complexes.
Is caveolin-mediated endocytosis involved in brain signaling?
Yes, endocytosis of dopamine receptors is part of brain signaling, and caveolin-mediated transcytosis contributes to delivery of large cargoes into the brain.
What CRISPR models are used to study this pathway?
Knockout, point-mutation, knock-in and overexpression models are used to test necessity, sufficiency and the role of specific residues in regulating caveolin-mediated endocytosis.
Conclusion
GO:2001286 (regulation of caveolin-mediated endocytosis) captures a tunable, signaling-sensitive process that controls how cells internalize cargo through caveolae. Its regulators, including CAV1, RAB21 and signaling pathways such as PI3K-Akt and Src-JNK, determine the rate of uptake and the fate of cargo, with consequences for ion channel surface expression, neuronal development and therapeutic delivery. Because the pathway is both biologically central and therapeutically exploitable, precise genetic models are essential. CRISPR knockout, point-mutation, knock-in and overexpression approaches, combined with quantitative imaging and proteomics, provide the causal evidence needed to move from correlation to mechanism.
References
- 1. Yin L et al.. 2022. Characterization of the MicroRNA Profile of Ginger Exosome-like Nanoparticles and Their Anti-Inflammatory Effects in Intestinal Caco-2 Cells.. J Agric Food Chem 70(15):4725-4734 PMID: 35261246
- 2. Means N et al.. 2022. Revealing macropinocytosis using nanoparticles.. Mol Aspects Med 83:100993 PMID: 34281720
- 3. Seaberg J et al.. 2025. Enhancing mRNA therapy through iterative delivery.. Sci Adv 11(40):eadx0916 PMID: 41032607
- 4. Pandit R et al.. 2020. Role for caveolin-mediated transcytosis in facilitating transport of large cargoes into the brain via ultrasound.. J Control Release 327:667-675 PMID: 32918963
- 5. Wolf MT et al.. 2013. Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis.. Kidney Int 84(1):130-7 PMID: 23466996
- 6. Kawahata I et al.. 2023. Endocytosis of dopamine receptor: Signaling in brain.. Prog Mol Biol Transl Sci 196:99-111 PMID: 36813367
- 7. Liu Y et al.. 2024. Cell entry of bovine respiratory syncytial virus through clathrin-mediated endocytosis is regulated by PI3K-Akt and Src-JNK pathways.. Front Microbiol 15:1393127 PMID: 38690369
- 8. Shikanai M et al.. 2023. Rab21 regulates caveolin-1-mediated endocytic trafficking to promote immature neurite pruning.. EMBO Rep 24(3):e54701 PMID: 36683567
